Peritonitis

Peritonitis is a topic covered in the Guide to Diagnostic Tests.

To view the entire topic, please or .

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Explore these free sample topics:

-- The first section of this topic is shown below --

Organism

Peritonitis

Primary or spontaneous (associated with nephrosis or cirrhosis) (SBP): Enterobacteriaceae (GNR) (69%), enterococci (GPC), viridans streptococci (GPC in chains), S. pneumoniae (GPC), group A streptococcus (GPC), S. aureus (GPC), anaerobes (5%).

Secondary (bowel perforation, hospital acquired, or antecedent antibiotic therapy): Enterobacteriaceae, enterococcus (GPC), Bacteroides fragilis group (GNR), Pseudomonas aeruginosa (GNR) (3–15%).

Chronic ambulatory peritoneal dialysis (CAPD): Coagulase-negative staphylococci (GPC) (43%), S. aureus (14%), Streptococcus sp. (12%), Enterobacteriaceae (14%), Pseudomonas aeruginosa, Corynebacterium sp. (GPR), candida (2%), aspergillus (rare), cryptococcus (rare).

-- To view the remaining sections of this topic, please or --

Organism

Peritonitis

Primary or spontaneous (associated with nephrosis or cirrhosis) (SBP): Enterobacteriaceae (GNR) (69%), enterococci (GPC), viridans streptococci (GPC in chains), S. pneumoniae (GPC), group A streptococcus (GPC), S. aureus (GPC), anaerobes (5%).

Secondary (bowel perforation, hospital acquired, or antecedent antibiotic therapy): Enterobacteriaceae, enterococcus (GPC), Bacteroides fragilis group (GNR), Pseudomonas aeruginosa (GNR) (3–15%).

Chronic ambulatory peritoneal dialysis (CAPD): Coagulase-negative staphylococci (GPC) (43%), S. aureus (14%), Streptococcus sp. (12%), Enterobacteriaceae (14%), Pseudomonas aeruginosa, Corynebacterium sp. (GPR), candida (2%), aspergillus (rare), cryptococcus (rare).

There's more to see -- the rest of this entry is available only to subscribers.